Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
For my follow up act, I will do a comparison analysis of rent costs of NWBO and CLDX later tonight when I get home from my day job (yes some of us actually have to work at real jobs for a living as opposed to bashing companies) that way we will be able to compare apples to apples and see what comparative rental costs are for biotech companies without any FDA approved products....
Hint I just did a brief review and the results are shocking! So when people want to argue that NWBO are overpaying for rent, we will all have real information to provide a valid comparison, as opposed to unsubstantiated opinions.
There are two offices in two countries and 11000 square ft. No one is high fiveing anyone just pointing out the facts, that the arguments of sweet heart deal for cognate or toucan at rates above market price on a location basis does not appear to be accurate.
The BS is coming from ready, not you or me. Ready has a problem with facts.
The fact is that combined rent for two office on a per month cost is $34,666 for the 2015, 2016, 2017, and roughly $17,333.33 for three months of 2018. Hardly overpaying for rent of 11,000 combined square ft per month... fact. Cutting through your Bull...., fact.
My thoughts are that there is a lake of risk taking by big money for the whole biotech sector, that coupled with current silence, and the most recent cash raise has a dampening effect on NWBO pps. My opinion is that this is temporary and upon updates, which I believe will be positive and/or clear up outstanding issues, that the price will appreciate. The amount of appreciation depends on the updates. There could be small updates, there could be huge updates, there could be bad news (I don't think the news will be bad although I am certain that with any news there will be certain individuals that will claim any positive news is in fact negative or invalid).
I am as frustrated as Austin, more so with the FDA than with NWBO, but I have come to understand that all my belly aching will do nothing. If venting is needed then there are other more productive ways to vent frustration.
I find many here to be plants to foment frustration in others so that they grow to hate their investment. I just provided a brief analysis of financial statements to provide clarity on what some belly acher's on here wanted to drum up the idea that NWBO is overpaying for rent and costing us our money. With facts taken from the financial statements it appears that those who were spouting opinions of overpaying appear to be way off, and I am now reassured by my brief analysis that we are most likely paying market rates for rent, maybe a little more, maybe a little less, but not a total waste of money funneling our hard earned (mine at least) investment dollars.
Facts often have a way of cutting through bull s...
Ok let's do a quick analysis of an estimate of cost per sq ft
As of 12/31/14 future obligations equaled $1.3 million
agreement #1 is 7097 sq ft and expires on 03/2018 (39 months (2015, 2016, 2017, 3 months in 2018))
agreement #2 is 4251 sq ft and expires on 12/2017 (36 months (2015, 2016, 2017)
$1,300,000 / 75 (39 +36) months = $17,333.33 per month per location (estimate on location cost but confirmed total cost, as one location may be more or less than the other, but the total cost is as stated).
Or lets look at sq ft cost
Agreement #1 is 7097 sq ft and estimated to be $17,333.33 per month, or $2.44 per sq ft.
Agreement #2 is 4251 sq ft and estimated to be $17,333.33 per month, or $4.07 per sq ft.
The actual rent per unit may be different, but based on the number of months left on the contracts and the sq ft identified, that is a rough calculation of the cost per month and cost per sq ft for each location.
Answer = post #54689
We were told 90 days from December 8th, your facts are incorrect
How much would you like to bet on news relating to one of the three possible outcomes being PR'd in March?
What was the most recent quarters cash burn? What was the most recently reported cash burn rate relative to the rate prior to that period? What was the trajectory of the cash burn rate?
Now for the difficult questions
What have they spent since the most recently reported quarter? What was the cash burn rate for 10/15-12/31/15? How much cash was left on hand at 12/31/15?
Ready you are a tool
You cannot answer the difficult questions, you can only fill in your opinion or take past information and project it forward, which is meaningless because you have no clue how they are spending their money.
Well here is another piece of data, last year NWBO filed their annual 10-K on March 17th. This is another big piece of missing data that everyone is looking forward to reviewing to get an idea how much cash is on hand at 12/31/15. As we all now the cash burn is not fixed so, there is no idea where they are with cash right now, today. The only thing we know is that there were two cash raises since the last financial statement has been reported and in that set of financial statements they had roughly 5 million in cash on hand at 9/30/15.
I anticipate that we will get the investigation outcome, financial statements, and explanation of temporary clinical hold in March of 2016.
Where is the fast forward button!!!
As enjoyable as this two day stretch is, we still have a long way to go.
Based on the Dec 8th PR stating the investigation will take at least 90 days will put us into mid March (under the assumption that they began the investigation shortly after the PR as they indicated they would in the PR).
I certainly hope we get resolution of the investigation by mid March or sooner.
Regarding the trial temp halt, my preference for resolution is much sooner than mid March.
I recall the note from Les included with or supplemental to the cash raise before Christmas, when he stated that they were raising the cash in anticipation of a busy new year.....well Les it's the new year, may we the shareholders receive some updates on what NWBO has been busy working on? Please?
Hahaha, it's not a pyramid it's a multi tiered marketing plan!
Yup, the whole team was out in full force, applying their trade from all angles.
1 out of 3 ain't bad!
I answered your question twice
Also to get more profit from the short you should setup a few pumpers who spend all day pumping stocks to get more people to buy, then short the stock after the pump, then release said report, for maximum profit. After longs become weary, assault them relentlessly to elicit self anger and emotional reaction to sell, buy back the short closing the trade taking profit, repeat.
Answer, for profit.
If you would like an example, Adam you don't have to go far, just call your friend Martin. He could tell you all about his citizen protests to the FDA trying to halt clinical studies that showed promise (some even were approved by the FDA after his citizen protests, which were filled with false reports and false research to attempt to support his protest).
You see Adam, you are the company you keep, and you work with Jim Cramer and have ties/worked with Martin Shkrelli who is currently under indictment. I think that is what people consider a criminal cabal of those bent on slowing/stopping/destroying clinical trials for profit.
Correct, these sideliners have seemingly limitless time on their hands. No day job requiring their attention, no financial position in the companies they spend all their time writing about........strange misapplication of time if you ask me.
Furthermore if these sideliners are misapplying their time in such a manner why should anyone take what they say seriously when they clearly are wasting their time daily writing about something they KNOW will fail, as opposed to working a day job or investing in other profitable endeavors?
So on one hand the company is not disclosing enough data to make reasonable conclusions from the data, and on the other hand we should listen to the data that the company is providing (when others run through machinations of calculations based on estimates to determine the outcome)?
Interesting....
Do you recall when the company said that all the trial modeling done by outsiders will prove useless? That was in response to PYR way back when PYR was a NWBO cheerleader.
based on the December 8th PR they (NWBO) mentions that the investigation is expected to get under way soon and is expected to take at least 90 days. If the investigation did start a few days after the PR that would put the finalization around mid March.
This is investment has become exhausting. I even bought more recently around $2.02.
the answer is both buy and sell
BETHESDA, MD, December 8, 2015 – Northwest Biotherapeutics (NASDAQ: NWBO) (“NW Bio”), a U.S. biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, announced today that a Special Committee has been established by the Board of Directors to oversee an independent investigation of recent allegations in an anonymous internet report and a derivative lawsuit which cites the anonymous internet report. The Special Committee has selected a highly experienced independent law firm to lead an Investigation Team to conduct the investigation.
In establishing the Special Committee, the Board authorized the Committee to conduct a full and complete investigation of the allegations in the anonymous report and the lawsuit. As is customary in such matters, the Special Committee is comprised of independent Directors Mr. Jerry Jasinowski and Mr. Robert Farmer.
The Company is also in the process of finalizing the appointment of another independent Director to the Board, as previously announced.
Mr. Jasinowski commented: “As we announced last week, we welcome Mr. Woodford’s recent call for an investigation to address the allegations in a recent anonymous internet report and lawsuit, and we agree with Mr. Woodford that the investigation needs to be fully independent. We are particularly pleased that after considering various possibilities, we have selected accomplished, experienced, respected and fully independent parties to assist us in the investigation.”
The Special Committee considered various candidates to head the Investigation Team and selected Messrs. Irvin Nathan and Steven Kaplan of Arnold & Porter LLP. Neither Arnold & Porter LLP nor Mr. Nathan or Mr. Kaplan has previously done any work for NW Bio, or otherwise been connected with the Company or its Board or management.
Mr. Nathan’s background includes service in the Justice Department as a Deputy Assistant Attorney General, as well as service as General Counsel for the U.S. House of Representatives, Attorney General of the District of Columbia, Vice Chairman of the D.C. Board of Professional Responsibility and Chair of the Ethics Committee of the D.C. Bar, as well as many years in private practice and extensive experience in conducting investigations.
Mr. Kaplan’s background includes heading the Corporate and Securities law practice of Arnold & Porter LLP, with extensive experience with corporate governance and internal investigations, in addition to securities law compliance, capital markets and mergers and acquisitions.
The Special Committee anticipates that the investigation will get under way in the coming week and will likely take at least 90 days.
as well as
Mr. Charles Price has been engaged to be available as a resource for the independent investigation, and to help seek action by the authorities in regard to manipulation of the Company’s stock. Mr. Price is a highly decorated, nationally recognized former FBI Special Agent and certified public accountant (CPA) who retired from the FBI approximately a year ago after a 28-year career with the Bureau, and is now a Managing Director with MorganFranklin Consulting, LLC where he is a leader in their Corporate Investigations and Dispute Solutions practice. Mr. Price received the FBI Director’s Award for Excellence in HUMINT (human intelligence), the Bureau’s highest award, in 2011, and received more than a dozen Outstanding Public Service Awards from US Attorney’s offices, as well as numerous commendations and awards from the FBI for excellence in investigation. Prior to joining the FBI, Mr. Price worked as a CPA at Arthur Andersen & Co. performing financial statement audits in the financial services industry.
The investigation is twofold, one investigation is internally focused as NW wanted, and a separate and second investigation is external based on market manipulation issues the company believes are happening and negatively affecting shareholder value.
How people still obfuscate this is alarming
Timeline of investigation based on PR from NWBO. On December 8th NWBO PR's that they expected to begin the investigation by the end of the week and that the investigation would take at least 90 days.
That would be roughly the week of March 7th-11th.
I must confess that I have little hope of any positive/material presentations at ASCO this year.
These days are truly sad days. Quite discouraged with the circumstances both external of NWBO and internal of NWBO.
My hope is that the investigation does not take 90 days.
NWBO management what is the cause of the trial temporarily halting?
Adam acts like this guy who is about to talk to congress
Shkreli said he plans to keep mum.
“They can ask me any question. ‘What color is the sky?’ Fifth Amendment.”
Your argument is rendered feeble by two reasons, first Smith's last article where he mentioned Financial Position is Weak; there is a Need for Much More Cash
and
There is a great deal of uncertainty on the potential for success in this trial. If at the end of 2016, you assign a probability of success of 20%
You see balanced
AF try it some time, Try to get AF to say something like
If the data is as it portrays then the possibility of successfully meeting the endpoints is X%
He will not entertain the possibility of a successful trial, despite the fact that it could finish successfully surpassing its endpoints.
Feeble arguments cannot stand on their own, pal. Yours is a feeble argument.
I have had my questions deleted by AF or some editor at the street, so your point is?
You cannot refute my question earlier that superseded any of your feeble arguments.
Does Smith acknowledge that DCVax-L can fail?
Does AF acknowledge that DCVax-L can succeed?
A truly balanced approach would acknowledge both alternatives as possible outcomes because they are both possible, but AF will not, which is not balanced because it does not fit his narrative.
Here is why your argument is incorrect that AF is the Yin to Smith's Yang.
Smith, the supposed pumper, can admit and has acknowledged that DCVax-L could fail. Smith's most recent article was quite balanced.
AF the biased blogger, will not admit or acknowledge that DCVax-L could achieve FDA approval.
Plain and simple.
Smith can DCVac-L fail? answer = Yes
Adam can DCvax-L achieve FDA approval? answer = No
AF would argue that the FDA wants to make sure those that suffer from glioblastoma don't also suffer from scurvy.
In case you didn't know scurvy is caused by a lack of vitamin C, ie lack of grapefruit juice.
Adam would you care to relay the question posted by GoodGuyBill to one of your sources so that your sources can do some research and you can pass off their research as your own?
Exactly, or any fund/investment that TST stock participates in. Are there any conflicts of interest there?
Does the street.com retirement plan hold any investments in firms that have any position in NWBO?
Your disclaimer states that you do not own shares of any of the stocks you write about, but that you own shares in TST (The Street), what are the holdings of TST? Does TST invest in any hedge funds that have positions in any of the stocks you write about?
Also as a bit of advice to you, maybe you should not have anything invested in TST as the stock is a garbage dump and at 10yr lows.
I would feel bad for you if you were an upstanding individual. Maybe you should write about how people should not invest in the toxic dump that is TST.
Haha, you got it
Oh I know, I just wanted to throw a little dirt their way, as I am of the impression the writers of the Phase V report frequent this board.
I think Phase V owes everyone an explanation as to why their website is temporarily halted
Hi Longfellow, thank you for the news. I only made my post because I noticed that your original post was deleted. Thank you again
For those critics of NWBO and the supporters of NWBO, the web service to the Phase V account has been limited temporarily. In other words they are experiencing a temporary halt!
The problem with continue at this time is that it will allow for obfuscation from shorts who would argue that continue means that the results are not good enough for acceptance, FDA will have no problem with continuance because of lack of safety issues, and management has an interest in keeping the trial going as long as possible to continue to dilute.
We need something better than continuation to break the price upward.
I noticed a decent recommendation earlier today on YMB (seriously)
Apparently the new trend is to buy NWBO on Thursday and sell into the Friday rally.
Are you? Your golden stock CLDX has been anything but since you wrote your gleaming piece after ASCO last year. Do you feel responsible for the people who bought CLDX because of your piece and are now losing money?
You see the same promoting smear attacks can be thrown right back at you pal!
You promoted CLDX and people are losing because of it, plain and simple.